AstraZeneca
Global biopharma with strong oncology and cardiometabolic franchises and a broad pipeline.
Therapeutic areas
Selected products and programs
Linked curated drug profiles
TROP2-directed antibody-drug conjugate
trastuzumab deruxtecanHER2-directed antibody-drug conjugate
Selected active clinical trials
Phase 3 · Recruiting · Metastatic Non-small Cell Lung Cancer
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney FunctionPhase 3 · Recruiting · Heart Failure and Impaired Kidney Function
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine TherapyPhase 3 · Recruiting · Breast Cancer, Early Breast Cancer
A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes MellitusPhase 3 · Recruiting · Obesity
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)Phase 3 · Recruiting · Breast Cancer
A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.Phase 3 · Recruiting · Hypercholesterolaemia
Selected patent records
dapagliflozin · Expires 2025-10-04
US 6515117*PEDdapagliflozin · Expires 2026-04-04
US 8329648dapagliflozin · Expires 2026-08-18
US 8906851dapagliflozin · Expires 2026-08-18
US 8329648*PEDdapagliflozin · Expires 2027-02-18
US 8906851*PEDdapagliflozin · Expires 2027-02-18
Primary and company sources
Company and pipeline information can change. Verify material decisions against the linked primary sources.
Evidence & limits
Source: Open the source record
- Record identifier
- /companies/astrazeneca/
- Event / action date
- Not separately retained
- Source update date
- Not separately retained
- Platform retrieval / processing date
- Not separately retained
What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.
Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.
Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.